Testing effectiveness (Phase 2)Study completedNCT02405338What this trial is testingDC Vaccination for Post-remission Therapy in AMLWho this might be right forAcute Myeloid Leukemia Medigene AG 20
Testing effectiveness (Phase 2)Study completedNCT00134004What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 210
Large-scale testing (Phase 3)Study completedNCT00661999What this trial is testingDarbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With CancerWho this might be right forAnemiaLeukemiaLymphoma+4 more Mayo Clinic 502
Not applicableUnknownNCT05152537What this trial is testingFLOR3 Gene Polymorphism in Predicting Outcomes of Tyrosine Kinase Inhibitor（TKI）Stopping in Chronic Myeloid LeukemiaWho this might be right forFolateCMLTreatment-free Remission Affiliated Hospital of Nantong University 15
Not applicableLooking for participantsNCT05909293What this trial is testingClinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete RemissionWho this might be right forAcute Myeloid Leukemia The First Affiliated Hospital with Nanjing Medical University 100
Early research (Phase 1)Study completedNCT02446964What this trial is testingTotal Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute LeukemiaWho this might be right forAdult Acute Lymphoblastic Leukemia in Complete RemissionAcute Myeloid Leukemia in RemissionPreviously Treated Myelodysplastic Syndrome+5 more City of Hope Medical Center 31
Large-scale testing (Phase 3)UnknownNCT00454168What this trial is testingVaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in RemissionWho this might be right forLeukemia The Vaccine Company 244
Early research (Phase 1)Study completedNCT00376480What this trial is testingLaboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell TransplantWho this might be right forLeukemiaMyelodysplastic Syndromes Dana-Farber Cancer Institute 19
Testing effectiveness (Phase 2)Study completedNCT00008190What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute LeukemiaWho this might be right forLeukemia Herbert Irving Comprehensive Cancer Center
Large-scale testing (Phase 3)UnknownNCT02059720What this trial is testingHaplo-SCT vs ASCT With or Without Decitabine in AML CR1Who this might be right forAcute Myeloid Leukemia The First Affiliated Hospital of Soochow University 212
Testing effectiveness (Phase 2)Study completedNCT00365287What this trial is testingCombination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerWho this might be right forBreast CancerKidney CancerLeukemia+3 more Masonic Cancer Center, University of Minnesota 148
Early research (Phase 1)Study completedNCT00030108What this trial is testingIxabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more National Institutes of Health Clinical Center (CC) 30
Not applicableNo Longer AvailableNCT03409081What this trial is testingEarly Access Program (EAP) of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or With FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)Who this might be right forAcute Myeloid Leukemia (AML)FMS-like Tyrosine Kinase-3 (FLT3) Mutations Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Study completedNCT00253513What this trial is testingTreosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes OHSU Knight Cancer Institute 60
Testing effectiveness (Phase 2)Study completedNCT00002809What this trial is testingBone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Temple University 10
Testing effectiveness (Phase 2)UnknownNCT01513109What this trial is testingSafety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid LeukemiaWho this might be right forAcute Myelogenous LeukemiaMyeloid Leukemia in RemissionEffects of Immunotherapy Jules Bordet Institute 20
Not applicableUnknownNCT05926128What this trial is testingStudy of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic PhaseWho this might be right forCML Fundaleu 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT03610971What this trial is testingTreatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase InhibitorsWho this might be right forChronic Phase Chronic Myeloid LeukemiaChronic Myeloid Leukemia, Chronic Phase H. Lee Moffitt Cancer Center and Research Institute 24
Not applicableStudy completedNCT04617145What this trial is testingAerobic Versus Resistive Training on Functional Capacity in Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia in Remission Cairo University 60
Testing effectiveness (Phase 2)Study completedNCT00004905What this trial is testingCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute LeukemiaWho this might be right forLeukemia Loyola University